Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 629

1.

The Impact of Exclusive Use of Very Low Nicotine Cigarettes on Compensatory Smoking: An Inpatient Crossover Clinical Trial.

Smith TT, Koopmeiners JS, White CM, Denlinger-Apte RL, Pacek LR, De Jesús VR, Wang L, Watson C, Blount BC, Hatsukami DK, Benowitz NL, Donny EC, Carpenter MJ.

Cancer Epidemiol Biomarkers Prev. 2020 Feb 26. doi: 10.1158/1055-9965.EPI-19-0963. [Epub ahead of print]

PMID:
32102910
2.

Mouth-Level Nicotine Intake Estimates from Discarded Filter Butts to Examine Compensatory Smoking in Low Nicotine Cigarettes.

Smith TT, Koopmeiners JS, Hatsukami DK, Tessier KM, Benowitz NL, Murphy SE, Strasser AA, Tidey JW, Blount BC, Valentin L, Bravo Cardenas R, Watson C, Pirkle JL, Donny EC.

Cancer Epidemiol Biomarkers Prev. 2020 Mar;29(3):643-649. doi: 10.1158/1055-9965.EPI-19-0905. Epub 2020 Feb 26.

PMID:
32102909
3.

Comparison of smoking cessation rates of Quitline users in Korea between smokers of ultra-low nicotine yield cigarettes and other types of cigarette: a prospective study.

Park EY, Park E, Jeong BY, Park J, Lee DH, Benowitz NL, Lim MK.

Addiction. 2020 Feb 21. doi: 10.1111/add.15021. [Epub ahead of print]

PMID:
32083364
4.

Relationships between the Nicotine Metabolite Ratio and a Panel of Exposure and Effect Biomarkers: Findings from Two Studies of U.S. Commercial Cigarette Smokers.

Carroll DM, Murphy SE, Benowitz NL, Strasser AA, Kotlyar M, Hecht SS, Carmella SG, McClernon FJ, Pacek LR, Dermody SS, Vandrey RG, Donny EC, Hatsukami DK.

Cancer Epidemiol Biomarkers Prev. 2020 Feb 12. doi: 10.1158/1055-9965.EPI-19-0644. [Epub ahead of print]

PMID:
32051195
5.

The Role of Compensation in Nicotine Reduction.

Benowitz NL, Donny EC, Edwards KC, Hatsukami D, Smith TT.

Nicotine Tob Res. 2019 Dec 23;21(Suppl 1):S16-S18. doi: 10.1093/ntr/ntz120.

6.

Effects of Very Low Nicotine Content Cigarettes on Smoking Behavior and Biomarkers of Exposure in Menthol and Non-menthol Smokers.

Denlinger-Apte RL, Kotlyar M, Koopmeiners JS, Tidey JW, Luo X, Benowitz NL, Jensen JA, Ikuemonisan JO, Pacek LR, Smith TT, Vandrey R, Donny EC, Hatsukami DK.

Nicotine Tob Res. 2019 Dec 23;21(Suppl 1):S63-S72. doi: 10.1093/ntr/ntz160.

7.

Sources and Biomarkers of Secondhand Tobacco Smoke Exposure in Urban Adolescents.

Nardone N, Jain S, Addo N, St Helen G, Jacob P 3rd, Benowitz NL.

Acad Pediatr. 2019 Dec 20. pii: S1876-2859(19)30515-7. doi: 10.1016/j.acap.2019.12.006. [Epub ahead of print]

PMID:
31866460
8.

Seizures After Vaping Nicotine in Youth: A Canary or a Red Herring?

Benowitz NL.

J Adolesc Health. 2020 Jan;66(1):1-2. doi: 10.1016/j.jadohealth.2019.10.016. No abstract available.

PMID:
31866053
9.

Twenty-four-hour subjective and pharmacological effects of ad-libitum electronic and combustible cigarette use among dual users.

Harvanko AM, St Helen G, Nardone N, Addo N, Benowitz NL.

Addiction. 2019 Dec 14. doi: 10.1111/add.14931. [Epub ahead of print]

PMID:
31837232
10.

Biomarkers of Exposure for Dual Use of Electronic Cigarettes and Combustible Cigarettes: Nicotelline, NNAL, and Total Nicotine Equivalents.

Jacob P, St Helen G, Yu L, Nardone N, Havel C, Cheung P, Benowitz NL.

Nicotine Tob Res. 2019 Dec 13. pii: ntz235. doi: 10.1093/ntr/ntz235. [Epub ahead of print]

PMID:
31833541
11.

Characterization of Nicotine Salts in 23 Electronic Cigarette Refill Liquids.

Harvanko AM, Havel CM, Jacob P, Benowitz NL.

Nicotine Tob Res. 2019 Dec 10. pii: ntz232. doi: 10.1093/ntr/ntz232. [Epub ahead of print]

PMID:
31821492
12.

The influence of nicotine metabolic rate on working memory over 6 hours of abstinence from nicotine.

Nardone N, Shahid M, Strasser AA, Dempsey DA, Benowitz NL.

Pharmacol Biochem Behav. 2020 Jan;188:172836. doi: 10.1016/j.pbb.2019.172836. Epub 2019 Dec 5.

PMID:
31812759
13.

Effect of e-cigarette flavors on nicotine delivery and puffing topography: results from a randomized clinical trial of daily smokers.

Voos N, Smith D, Kaiser L, Mahoney MC, Bradizza CM, Kozlowski LT, Benowitz NL, O'Connor RJ, Goniewicz ML.

Psychopharmacology (Berl). 2020 Feb;237(2):491-502. doi: 10.1007/s00213-019-05386-x. Epub 2019 Nov 26.

PMID:
31773209
14.

Effects of Nicotine Metabolic Rate on Cigarette Reinforcement.

Liakoni E, Nardone N, St Helen G, Dempsey DA, Tyndale RF, Benowitz NL.

Nicotine Tob Res. 2019 Nov 14. pii: ntz210. doi: 10.1093/ntr/ntz210. [Epub ahead of print]

PMID:
31725872
15.

Differences in nicotine intake and effects from electronic and combustible cigarettes among dual users.

St Helen G, Nardone N, Addo N, Dempsey D, Havel C, Jacob P 3rd, Benowitz NL.

Addiction. 2020 Apr;115(4):757-767. doi: 10.1111/add.14884. Epub 2020 Jan 6.

PMID:
31691397
16.

Current advances in research in treatment and recovery: Nicotine addiction.

Prochaska JJ, Benowitz NL.

Sci Adv. 2019 Oct 16;5(10):eaay9763. doi: 10.1126/sciadv.aay9763. eCollection 2019 Oct. Review.

17.

Corrigendum to: Changes in Use Patterns Over 1 Year Among Smokers and Dual Users of Combustible and Electronic Cigarettes.

Piper ME, Baker TB, Benowitz NL, Jorenby DE.

Nicotine Tob Res. 2019 Oct 14. pii: ntz164. doi: 10.1093/ntr/ntz164. [Epub ahead of print] No abstract available.

PMID:
31609417
18.

Biochemical Verification of Tobacco Use and Abstinence: 2019 Update.

Benowitz NL, Bernert JT, Foulds J, Hecht SS, Jacob P, Jarvis MJ, Joseph A, Oncken C, Piper ME.

Nicotine Tob Res. 2019 Oct 1. pii: ntz132. doi: 10.1093/ntr/ntz132. [Epub ahead of print]

PMID:
31570931
19.

E-Hookah Versus E-Cigarettes: Findings From Wave 2 of the PATH Study (2014-2015).

Rezk-Hanna M, Toyama J, Ikharo E, Brecht ML, Benowitz NL.

Am J Prev Med. 2019 Nov;57(5):e163-e173. doi: 10.1016/j.amepre.2019.05.007. Epub 2019 Sep 27.

PMID:
31564602
20.

Comparison of Systemic Exposure to Toxic and/or Carcinogenic Volatile Organic Compounds (VOC) during Vaping, Smoking, and Abstention.

St Helen G, Liakoni E, Nardone N, Addo N, Jacob P 3rd, Benowitz NL.

Cancer Prev Res (Phila). 2020 Feb;13(2):153-162. doi: 10.1158/1940-6207.CAPR-19-0356. Epub 2019 Sep 25.

PMID:
31554628
21.

Relationship between skin melanin index and nicotine pharmacokinetics in African American smokers.

Liakoni E, St Helen G, Dempsey DA, Jacob P 3rd, Tyndale RF, Benowitz NL.

Drug Alcohol Depend. 2019 Nov 1;204:107474. doi: 10.1016/j.drugalcdep.2019.04.039. Epub 2019 Aug 30.

PMID:
31521954
22.

E-cigarettes and dual nicotine replacement therapy for smoking cessation.

Benowitz NL.

Lancet Respir Med. 2020 Jan;8(1):7-8. doi: 10.1016/S2213-2600(19)30308-X. Epub 2019 Sep 9. No abstract available.

PMID:
31515174
23.

Exposure to a Tobacco-Specific Carcinogen Among Adolescent Smokeless Tobacco Users in Rural California, United States.

Chaffee BW, Jacob P, Couch ET, Benowitz NL.

Nicotine Tob Res. 2019 Aug 23. pii: ntz147. doi: 10.1093/ntr/ntz147. [Epub ahead of print]

PMID:
31504879
24.

Impact of early nausea on varenicline adherence and smoking cessation.

Peng AR, Swardfager W, Benowitz NL, Ahluwalia JS, Lerman C, Nollen NL, Tyndale RF.

Addiction. 2020 Jan;115(1):134-144. doi: 10.1111/add.14810. Epub 2019 Nov 5.

PMID:
31502736
25.

Biomarkers of Exposure to Nicotine and Tobacco-specific Nitrosamines in Adolescent Blunt Users.

Nardone N, Jain S, Benowitz NL.

Nicotine Tob Res. 2019 Aug 21. pii: ntz144. doi: 10.1093/ntr/ntz144. [Epub ahead of print] No abstract available.

PMID:
31433049
26.

JUUL electronic cigarettes: Nicotine exposure and the user experience.

Nardone N, Helen GS, Addo N, Meighan S, Benowitz NL.

Drug Alcohol Depend. 2019 Oct 1;203:83-87. doi: 10.1016/j.drugalcdep.2019.05.019. Epub 2019 Aug 5.

PMID:
31408770
27.

Differences in exposure to toxic and/or carcinogenic volatile organic compounds between Black and White cigarette smokers.

St Helen G, Benowitz NL, Ko J, Jacob P, Gregorich SE, Pérez-Stable EJ, Murphy SE, Hecht SS, Hatsukami DK, Donny EC.

J Expo Sci Environ Epidemiol. 2019 Aug 12. doi: 10.1038/s41370-019-0159-9. [Epub ahead of print]

PMID:
31406274
28.

Cytisine for nicotine addiction treatment: a review of pharmacology, therapeutics and an update of clinical trial evidence for smoking cessation.

Tutka P, Vinnikov D, Courtney RJ, Benowitz NL.

Addiction. 2019 Nov;114(11):1951-1969. doi: 10.1111/add.14721. Epub 2019 Jul 19.

PMID:
31240783
29.

Effects of immediate versus gradual nicotine reduction in cigarettes on biomarkers of biological effects.

Hatsukami DK, Luo X, Heskin AK, Tang MK, Carmella SG, Jensen J, Robinson JD, Vandrey R, Drobes DJ, Strasser AA, al'Absi M, Leischow S, Cinciripini PM, Koopmeiners J, Ikuemonisan J, Benowitz NL, Donny EC, Hecht SS.

Addiction. 2019 Oct;114(10):1824-1833. doi: 10.1111/add.14695. Epub 2019 Jul 8.

PMID:
31140663
30.

Black Light Smokers: How Nicotine Intake and Carcinogen Exposure Differ Across Various Biobehavioral Factors.

St Helen G, Benowitz NL, Ahluwalia JS, Tyndale RF, Addo N, Gregorich SE, Pérez-Stable EJ, Cox LS.

J Natl Med Assoc. 2019 Oct;111(5):509-520. doi: 10.1016/j.jnma.2019.04.004. Epub 2019 May 11.

PMID:
31084916
31.

Changes in Use Patterns OVER ONE YEAR Among Smokers and Dual Users of Combustible and electronic cigarettes.

Piper ME, Baker TB, Benowitz NL, Jorenby DE.

Nicotine Tob Res. 2019 May 6. pii: ntz065. doi: 10.1093/ntr/ntz065. [Epub ahead of print]

PMID:
31058284
32.

Longitudinal stability in cigarette smokers of urinary eicosanoid biomarkers of oxidative damage and inflammation.

Carmella SG, Heskin AK, Tang MK, Jensen J, Luo X, Le CT, Murphy SE, Benowitz NL, McClernon FJ, Vandrey R, Allen SS, Denlinger-Apte R, Cinciripini PM, Strasser AA, al'Absi M, Robinson JD, Donny EC, Hatsukami DK, Hecht SS.

PLoS One. 2019 Apr 25;14(4):e0215853. doi: 10.1371/journal.pone.0215853. eCollection 2019.

33.

Stimulant drugs are associated with violent and penetrating trauma.

Armenian P, Effron Z, Garbi N, Dirks R, Benowitz NL, Gerona RR.

Am J Emerg Med. 2019 Apr;37(4):645-650. doi: 10.1016/j.ajem.2018.06.071. Epub 2018 Jul 3.

PMID:
30914133
34.

E-cigarette Dependence Measures in Dual Users: Reliability and Relations with Dependence Criteria and E-Cigarette Cessation.

Piper ME, Baker TB, Benowitz NL, Smith SS, Jorenby DE.

Nicotine Tob Res. 2019 Mar 15. pii: ntz040. doi: 10.1093/ntr/ntz040. [Epub ahead of print]

PMID:
30874804
35.

Urine Metabolites for Estimating Daily Intake of Nicotine From Cigarette Smoking.

Benowitz NL, St Helen G, Nardone N, Cox LS, Jacob P.

Nicotine Tob Res. 2020 Feb 6;22(2):288-292. doi: 10.1093/ntr/ntz034.

PMID:
30852610
36.

Randomized within-subject trial to evaluate smokers' initial perceptions, subjective effects and nicotine delivery across six vaporized nicotine products.

Voos N, Kaiser L, Mahoney MC, Bradizza CM, Kozlowski LT, Benowitz NL, O'Connor RJ, Goniewicz ML.

Addiction. 2019 Jul;114(7):1236-1248. doi: 10.1111/add.14602. Epub 2019 Apr 25.

PMID:
30851137
37.

Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial.

Anthenelli RM, Gaffney M, Benowitz NL, West R, McRae T, Russ C, Lawrence D, St Aubin L, Krishen A, Evins AE.

J Gen Intern Med. 2019 Jun;34(6):862-870. doi: 10.1007/s11606-019-04858-2. Epub 2019 Mar 7.

38.

Evaluation of a weighted genetic risk score for the prediction of biomarkers of CYP2A6 activity.

El-Boraie A, Taghavi T, Chenoweth MJ, Fukunaga K, Mushiroda T, Kubo M, Lerman C, Nollen NL, Benowitz NL, Tyndale RF.

Addict Biol. 2020 Jan;25(1):e12741. doi: 10.1111/adb.12741. Epub 2019 Feb 27.

PMID:
30815984
39.

Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers With Psychotic, Anxiety, and Mood Disorders in the EAGLES Trial.

Evins AE, Benowitz NL, West R, Russ C, McRae T, Lawrence D, Krishen A, St Aubin L, Maravic MC, Anthenelli RM.

J Clin Psychopharmacol. 2019 Mar/Apr;39(2):108-116. doi: 10.1097/JCP.0000000000001015.

40.

Loperamide associated torsades de pointes, in the setting of complete heart block at marginally supratherapeutic dosing (20mg/day).

Goodnough R, Nomura M, Badea A, Lynch KL, Benowitz NL, Tsutaoka B.

Clin Toxicol (Phila). 2019 Nov;57(11):1123-1124. doi: 10.1080/15563650.2019.1578369. Epub 2019 Feb 19. No abstract available.

PMID:
30777457
41.

High Carbon Monoxide Levels from Charcoal Combustion Mask Acute Endothelial Dysfunction Induced by Hookah (Waterpipe) Smoking in Young Adults.

Rezk-Hanna M, Mosenifar Z, Benowitz NL, Rader F, Rashid M, Davoren K, Moy NB, Doering L, Robbins W, Sarna L, Li N, Chang LC, Elashoff RM, Victor RG.

Circulation. 2019 May 7;139(19):2215-2224. doi: 10.1161/CIRCULATIONAHA.118.037375.

PMID:
30764644
42.

Managing Cannabis Use in Patients With Cardiovascular Disease.

Benowitz NL.

Can J Cardiol. 2019 Feb;35(2):138-141. doi: 10.1016/j.cjca.2018.12.033. Epub 2018 Dec 29. No abstract available.

PMID:
30760417
43.

Factors That Explain Differences in Abstinence Between Black and White Smokers: A Prospective Intervention Study.

Nollen NL, Mayo MS, Sanderson Cox L, Benowitz NL, Tyndale RF, Ellerbeck EF, Scheuermann TS, Ahluwalia JS.

J Natl Cancer Inst. 2019 Oct 1;111(10):1078-1087. doi: 10.1093/jnci/djz001.

44.

Association of Reduced Nicotine Content Cigarettes With Smoking Behaviors and Biomarkers of Exposure Among Slow and Fast Nicotine Metabolizers: A Nonrandomized Clinical Trial.

Mercincavage M, Lochbuehler K, Wileyto EP, Benowitz NL, Tyndale RF, Lerman C, Strasser AA.

JAMA Netw Open. 2018 Aug;1(4):e181346. doi: 10.1001/jamanetworkopen.2018.1346. Epub 2018 Aug 24.

45.

Identification and quantification of electronic cigarette exhaled aerosol residue chemicals in field sites.

Khachatoorian C, Jacob P 3rd, Sen A, Zhu Y, Benowitz NL, Talbot P.

Environ Res. 2019 Mar;170:351-358. doi: 10.1016/j.envres.2018.12.027. Epub 2018 Dec 16.

46.

Evaluating the temporal relationships between withdrawal symptoms and smoking relapse.

Robinson JD, Li L, Chen M, Lerman C, Tyndale RF, Schnoll RA, Hawk LW, George TP, Benowitz NL, Cinciripini PM.

Psychol Addict Behav. 2019 Mar;33(2):105-116. doi: 10.1037/adb0000434. Epub 2019 Jan 7.

47.

Longitudinal stability in cigarette smokers of urinary biomarkers of exposure to the toxicants acrylonitrile and acrolein.

Chen M, Carmella SG, Sipe C, Jensen J, Luo X, Le CT, Murphy SE, Benowitz NL, McClernon FJ, Vandrey R, Allen SS, Denlinger-Apte R, Cinciripini PM, Strasser AA, al'Absi M, Robinson JD, Donny EC, Hatsukami D, Hecht SS.

PLoS One. 2019 Jan 4;14(1):e0210104. doi: 10.1371/journal.pone.0210104. eCollection 2019.

48.

Reprint of: Prevention and Treatment of Tobacco Use: JACC Health Promotion Series.

Kalkhoran S, Benowitz NL, Rigotti NA.

J Am Coll Cardiol. 2018 Dec 11;72(23 Pt B):2964-2979. doi: 10.1016/j.jacc.2018.10.020. Review.

49.

2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents.

Barua RS, Rigotti NA, Benowitz NL, Cummings KM, Jazayeri MA, Morris PB, Ratchford EV, Sarna L, Stecker EC, Wiggins BS.

J Am Coll Cardiol. 2018 Dec 25;72(25):3332-3365. doi: 10.1016/j.jacc.2018.10.027. Epub 2018 Dec 5. Review. No abstract available.

50.

Butanediol Conversion to Gamma-Hydroxybutyrate Markedly Reduced by the Alcohol Dehydrogenase Blocker Fomepizole.

Liakoni E, Gugelmann H, Dempsey DA, Wiegand TJ, Havel C, Jacob P, Benowitz NL.

Clin Pharmacol Ther. 2019 May;105(5):1196-1203. doi: 10.1002/cpt.1306. Epub 2019 Jan 8.

Supplemental Content

Loading ...
Support Center